InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Explore the detailed record of transactions filed by John Volpone. Director active across 1 company, notably X4 Pharmaceuticals, Inc. Aggregated, 1 disclosures have been logged. Activity tracked since 12 August 2026. The latest transaction was disclosed on 12 August 2026 (Notice of proposed sale (Form 144)). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration